From Skin to Blood: A New Member Joins the iClub
Cell Stem Cell, ISSN: 1934-5909, Vol: 13, Issue: 2, Page: 131-133
2013
- 4Citations
- 31Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations4
- Citation Indexes4
- CrossRef3
- Captures31
- Readers31
- 31
Article Description
Transcription-factor-driven direct reprogramming allows lineage conversion of somatic cells that bypasses an intermediate pluripotent state. In this issue of Cell Stem Cell, Pereira et al. (2013) report the induction of cells with hemogenic potential from murine fibroblasts, an important step toward generating patient-specific hematopoietic (stem) cells for clinical application.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S1934590913003159; http://dx.doi.org/10.1016/j.stem.2013.07.007; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84881130767&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/23910075; https://linkinghub.elsevier.com/retrieve/pii/S1934590913003159
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know